NPCE vs PH · rev $79.9M vs P/E 28, rev $19.85B
Neuropace Inc (NPCE) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
NPCE currently screens at market cap $312.2M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the NPCE and PH stock pages for the full models.
Not investment advice.